Jornavax: Redefining Recovery Without Narcotics

Dr. Gould’s cutting-edge approach to pain relief using Nav1.7 inhibition

What is Jornavax?

Jornavax is a revolutionary non-opioid medication that targets the Nav1.7 sodium channel, the nerve pathway responsible for sending pain signals to the brain. Originally inspired by the discovery of a rare genetic mutation in Pakistani individuals who feel no pain, this breakthrough therapy allows for powerful pain relief without the risks of sedation, addiction, or slowed healing.

How It Works

Unlike narcotics that dull the brain’s perception of pain, Jornavax works at the source—blocking the pain signal from forming in the first place. Patient's experience:

• Dramatically reduced post-op pain
• No “foggy” feeling
• No addictive side effects
• Improved movement, mood, and healing

Dr. Gould’s Protocol

Dr. Gould’s patients begin Jornavax the night before surgery as part of a strategic preemptive pain plan. The medication is continued for 5–7 days after the procedure, depending on the type of surgery. When combined with other non-opioid strategies like Exparel, Tylenol, Celebrex, and red light therapy, this protocol delivers a luxury-level recovery experience.

Read our guide on what to expect after your first week of surgery.

Why It Matters

• Reduced opioid use: Patients rarely need narcotics—and when they do, it’s in far lower doses.
• Faster recovery: Early walking, less swelling, better sleep.
• Smarter healing: Less inflammation, less trauma to the nervous system.

Is It Right for Me?

Most patients undergoing facelifts, tummy tucks, breast surgeries, and body contouring are candidates for Jornavax. During your consultation, Dr. Gould will tailor a recovery plan that fits your needs, lifestyle, and medical background. Experience a recovery that matches the precision of your results. Book a consultation or learn more about our healing-enhanced surgical approach.